SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors rally behind the official launch of the pivotal Phase 3 AURORA trial for NSCLC and anticipation for the prostate cancer BLA submission later this year. The community is actively discussing the stock's significant long-term potential, citing a strong clinical pipeline, a recent strategic C-suite hire, and the expectation that the low float and heavy short interest could drive an explosive upward move.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors rotate into clean energy infrastructure following a strategic 380MW data center power deal that signals a shift from project proposals to active commercial execution. The community is actively debating the company's valuation gap compared to peers, while monitoring management's ability to convert pipeline demand into binding backlog and sustainable revenue.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending due to significant momentum in the 'Physical AI' sector, fueled by its new strategic manufacturing agreement for its REV8 sensor family and recent high-profile infrastructure deployments ahead of the 2026 World Cup. Community sentiment is largely focused on the company's critical role as an enabler for robotics and autonomous systems, with many investors debating whether current price action represents a sustainable breakout for long-term compounding or a high-volatility momentum play.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing significant volatility driven by intense competition from payment giants like Stripe, Visa, and Mastercard entering the stablecoin sector, alongside investor sensitivity to potential regulatory shifts regarding the Clarity Act. The community remains deeply divided, with some investors aggressively accumulating on dips due to long-term conviction in stablecoin adoption, while others are offloading positions amidst concerns over insider selling and weakening price support.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is experiencing significant volatility and trading momentum driven by a strong re-rating as investors pivot the stock toward an AI data center power infrastructure narrative. While the community is actively debating the sustainability of these gains versus potential short-squeeze dynamics, bullish sentiment is being further fueled by recent insider buying from the CEO and speculative interest in the company's new solid-state transformer technology.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is seeing intense momentum as the broader defense and drone sector rallies on expectations of significant government investment in autonomous systems. Investors are aggressively rotating into the stock, fueled by recent earnings-driven volatility and ongoing speculation regarding increased military budget allocations for drone-tech.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense community debate driven by its recent inclusion in the Russell 3000 index and ongoing speculation surrounding potential defense-sector supercycles and counter-drone contract opportunities. While bulls are focused on the company's autonomous systems partnerships and backlog growth, the stock is experiencing significant volatility as market participants clash over the impact of recent share dilution and heavy short interest.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is currently trending due to its official inclusion in the Nasdaq-100 index, a move that is triggering forced buying from passive index funds and increased institutional visibility. Community sentiment is divided, with many celebrating the stock's parabolic run as a core infrastructure beneficiary of the AI data center buildout, while skeptics are voicing concerns about its high valuation and recent insider selling.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently experiencing intense downward pressure as investors react to management's cautious commentary on its Watchman growth outlook, leading to a significant breakdown in price. The community is actively debating whether this represents a long-term value opportunity bolstered by ongoing share repurchases or a sign of deeper structural issues, with many traders looking for a capitulation point to enter a relief bounce.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing heavy selling pressure as investors scrutinize the company's aggressive debt-funded AI infrastructure expansion and potential concentration risk related to OpenAI. While the community remains divided between those viewing the steep price decline as a capitulation-driven buying opportunity and others concerned about long-term management strategy and capital allocation, sentiment is heavily influenced by intense algorithmic volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ELTP  
From CHATGPT:  
A company growing revenue at 100% year over year changes the picture significantly. 
 
For a generic drug company: 
 
100% YoY growth is rare. Most generic drug businesses grow in the low single digits or teens because the market is mature and highly competitive. 
If that growth is sustainable (not just from one acquisition or a one-time product launch), investors may be willing to pay a much higher revenue multiple. 
 
A rough framework: 
 
1–3× sales: Mature, slow-growth generic companies. 
4–7× sales: Strong growth, improving margins, or differentiated products. 
8–12× sales: Possible if the market believes the company can continue growing near 100%, expand margins, and eventually generate substantial earnings. 
15×+ sales: Usually reserved for biotech or software-like growth businesses, not traditional generics. 
 
 
Using today&#39;s revenue base, that implies roughly: 
 
Conservative: $0.60–$0.80/share 
Bull case: $0.90–$1.30/share 
Very aggressive: $1.50+

The mann

Luckycharm

t.b.

Lieutenant Joe

Doug

Trader King

Eric Sherman

Hunter Manucy

Brian Ericson

StockTwits Web

Elite Pharmaceuticals, Inc.

  
From CHATGPT:  
A company growing revenue at 100% year over year changes the picture significantly. 
 
For a generic drug company: 
 
100% YoY growth is rare. Most generic drug businesses grow in the low single digits or teens because the market is mature and highly competitive. 
If that growth is sustainable (not just from one acquisition or a one-time product launch), investors may be willing to pay a much higher revenue multiple. 
 
A rough framework: 
 
1–3× sales: Mature, slow-growth generic companies. 
4–7× sales: Strong growth, improving margins, or differentiated products. 
8–12× sales: Possible if the market believes the company can continue growing near 100%, expand margins, and eventually generate substantial earnings. 
15×+ sales: Usually reserved for biotech or software-like growth businesses, not traditional generics. 
 
 
Using today's revenue base, that implies roughly: 
 
Conservative: $0.60–$0.80/share 
Bull case: $0.90–$1.30/share 
Very aggressive: $1.50+